IPL, Q-Switched, or Picosecond: How the Three Main Light Treatments for Age Spots Actually Differ

Walk into three different dermatology offices with the same scattered brown spots on your hands and you may leave with three different recommendations: intense pulsed light, a Q-switched laser, or a picosecond laser. All three are legitimate. All three have published evidence behind them for solar lentigines, the flat brown marks most people call age spots. The confusion comes from the fact that they are often marketed interchangeably, when in reality they interact with pigment in meaningfully different ways.

Start with the target. An age spot is a cluster of keratinocytes overloaded with melanin, usually sitting in the epidermis and the very top of the dermis. Melanin absorbs light strongly across a wide band of the visible spectrum, especially in the green to red range. Every light-based treatment for lentigines exploits this: deliver energy that melanin absorbs faster than the surrounding tissue, and the pigmented cells are damaged selectively while normal skin is largely spared. This principle, selective photothermolysis, is the foundation of all three technologies. The differences lie in how fast the energy arrives.

IPL is a broadband flash, not a laser. Intense pulsed light devices emit a wide range of wavelengths, typically filtered to roughly 500 to 1200 nanometers, in pulses lasting milliseconds. That is slow in laser terms. The energy heats the pigmented spot, the spot darkens over a few days into a fine coffee-ground crust, and the crust exfoliates within one to two weeks. IPL covers large areas quickly, which makes it practical for a chest or forearms with dozens of spots, and it also improves redness and background sun damage at the same session. The trade-off: because the pulse is long and the wavelengths are broad, IPL deposits more bulk heat. In darker skin tones, where the surrounding epidermis also contains substantial melanin, that heat cannot discriminate well, and the risk of post-inflammatory hyperpigmentation or hypopigmentation rises considerably. Most conservative practice limits IPL for lentigines to lighter phototypes.

Q-switched lasers compress the energy into nanoseconds. A Q-switched device, commonly a 532 or 1064 nanometer Nd:YAG or a 694 nanometer ruby, delivers its pulse in billionths of a second. At that speed the mechanism shifts from pure heating toward a photoacoustic effect: the melanin-laden cells absorb energy faster than they can dissipate it, and the resulting rapid expansion fractures them mechanically. Less heat spreads to neighboring tissue, which is why Q-switched lasers have long been considered the workhorse for discrete lentigines. Clearance of an individual spot in one to two sessions is common. The visible aftermath is similar, a temporary darkening and micro-crust, sometimes with brief pinpoint whitening immediately after the pulse, which is an expected sign of adequate energy delivery, not a burn.

Picosecond lasers push the same idea further. Pulses measured in trillionths of a second shift the mechanism even more toward mechanical fragmentation and away from heat. In principle this means pigment can be shattered at lower fluences, with a smaller thermal footprint and a lower theoretical risk of rebound pigmentation. Comparative studies on lentigines have generally found picosecond devices at least as effective as Q-switched lasers, often with less post-treatment darkening, though the margin is smaller than marketing suggests and results depend heavily on operator settings. The clearest advantage appears in patients prone to post-inflammatory hyperpigmentation, where reducing collateral heat matters most. The clearest disadvantage is cost, since picosecond platforms are expensive and sessions are priced accordingly.

What the mechanisms predict in practice. For a light-skinned patient with many diffuse spots plus redness, IPL is efficient and reasonable. For a handful of well-defined lentigines, a Q-switched laser remains a strong, cost-effective standard. For medium to darker skin tones, or anyone with a history of pigmenting after minor injury, a picosecond device, or a cautiously dosed 1064 nanometer Q-switched laser, is the more defensible choice. In the darkest phototypes, many clinicians reasonably favor topical therapy or cryotherapy alternatives over any light device, because even short pulses cannot fully separate lesion melanin from background melanin.

Three caveats no device removes. First, none of these treatments prevents new spots, so daily broad-spectrum sunscreen is not optional aftercare, it is the maintenance plan. Second, any flat pigmented lesion that is new, changing, irregular, or unusually dark deserves dermoscopic evaluation before treatment, because lasering an unrecognized lentigo maligna delays a melanoma diagnosis. Third, expect a spot to look worse before it looks better. The darkening and crusting phase is the mechanism working, and picking at it is the most reliable way to turn a clean result into a scar or a stubborn pigment patch.

The honest summary: the physics differ more than the outcomes for the average light-skinned patient with typical lentigines. Skin tone, spot number, budget, and downtime tolerance should drive the choice, and a practitioner who asks about all four before recommending a platform is the one worth listening to.